Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer
Journal of Clinical Investigation · 03.09.2024 · 134 (17)
DOI: 10.1172/jci183675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 03.09.2024. Verfasst von Matthew L Steinhauser. Beteiligte Einrichtung: Center for Human Integrative Physiology, Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Intra-Abdominal Fat. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Obesity is a known driver of endometrial cancer. In this issue of the JCI, Gómez-Banoy and colleagues investigated a cohort of patients with advanced endometrial cancer treated with immune checkpoint inhibitors targeting the interaction between programmed cell death receptor-1 (PD-1) and its ligand (PD-L1). Notably, a BMI in the overweight or obese range was paradoxically associated with improved progression-free and overall survival. A second paradox emerged from CT analyses of visceral adipose tissue, viewed as an unhealthy fat depot in most other contexts, the quantity of which was also associated with improved treatment outcomes. Though visceral adiposity may have value as a biomarker to inform personalized treatment strategies, of even greater impact would be if a therapeutic strategy emerges from the future identification of adipose-derived mediators of this putative anticancer immune-priming effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Human Integrative Physiology, Aging Institute, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Division of Cardiovascular Medicine, Department of Medicine, University of Pittsburgh Medical Center and School of Medicine, Pittsburgh, Pennsylvania, USA.
Zitieren
APA
Steinhauser, M. L. (2024). Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer. Journal of Clinical Investigation, 134(17). https://doi.org/10.1172/jci183675
Vancouver
Steinhauser ML. Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer. Journal of Clinical Investigation. 2024;134(17). doi:10.1172/jci183675
BibTeX
@article{Steinhauser2024,
author = {Steinhauser, Matthew L},
title = {Unhealthy visceral fat is associated with improved efficacy of immunotherapy in endometrial cancer},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {17},
doi = {10.1172/jci183675}
}
EUVIMED